OR WAIT null SECS
February 09, 2024
The three non-commercial developers of ATMPs will benefit from enhanced support from the agency.
February 08, 2024
Through a €2.7 billion (US$2.9 billion) acquisition of MorphoSys, Novartis will get pelabresib, a late-stage drug candidate in development for cancer treatment.
February 07, 2024
The guidance discusses how to timely notify the agency of changes in production of APIs and finished products.
Purolite and Repligen have commercially launched a new CH1 affinity resin for the purification of specialized mAbs.
February 06, 2024
The addition of another amino acid recognizer as well as improvements in surface chemistry, reagents, and software expand the proteome coverage of Quantum-Si’s Platinum sequencing platform.
February 05, 2024
The CDMOs are joining together to offer end-to-end development and manufacturing services for protein expression systems and viral vectors in Europe.
Novo Holdings has entered into a merger agreement with Catalent and will acquire Catalent in a deal valued at $16.5 billion.
February 04, 2024
NICE has recommended the use of AbbVie's Tepkinly as a treatment option for eligible adults with diffuse large B-cell lymphoma.
February 03, 2024
ProductLife Group has announced its acquisition of Australian company Commercial Eyes.
February 02, 2024
The agency will coordinate intra-regional medicines regulation to strengthen the African regulatory network.